34 Weeks, BP 172/114, and a Request to Wait Until 37 Weeks
Ms. T., 29, gravida 2 para 1, is admitted at 34 weeks 2 days with a blood pressure of 172/114 mmHg confirmed on repeat after 10 minutes of left lateral rest, a persistent frontal headache, and new "flashing lights." She describes right upper quadrant pain and attributes it to heartburn. Deep tendon reflexes are 3+ with two beats of clonus; she has pitting edema to mid-shin. Labs: platelets 92 × 10⁹/L, AST 88 U/L, ALT 74 U/L, creatinine 0.9 mg/dL, urine protein-to-creatinine ratio 0.62. Fetal monitoring shows a baseline of 140 bpm, moderate variability, accelerations, and no decelerations. Cervix is 1 cm dilated, 50% effaced, −2 station; estimated fetal weight 2,100 g. Orders: magnesium sulfate 6 g IV over 20 minutes then 2 g/h; labetalol 20 mg IV; strict intake and output; continuous fetal monitoring. The nurse practitioner documents a category I tracing.
1. Classify her hypertensive disorder using her specific data, and explain which findings convert preeclampsia into preeclampsia with severe features.
Read the worked answer
Diagnosis: preeclampsia with severe features at 34 weeks 2 days.
It is preeclampsia because hypertension after 20 weeks is accompanied by proteinuria (protein-to-creatinine ratio 0.62, well above the 0.3 threshold).
What makes it severe - she meets four separate criteria, and any one would be sufficient:
- Systolic BP ≥160 and diastolic ≥110 mmHg - hers is 172/114, confirmed on repeat, which is the requirement before labeling it severe.
- New cerebral or visual symptoms - the flashing lights and the unrelenting frontal headache. The scotomata matter: they suggest cerebral vasogenic edema, not eyestrain.
- Thrombocytopenia - platelets 92 × 10⁹/L, below 100.
- RUQ/epigastric pain with transaminase elevation - AST 88 and ALT 74 with pain she has been calling heartburn. RUQ pain in this context is a hepatic capsule stretch sign and a warning of impending HELLP; the platelets and transaminases already show the hemolysis/platelet/liver axis beginning to move.
The creatinine of 0.9 mg/dL is not yet above the 1.1 threshold, so renal involvement is not the driver here. Her edema is supportive but not a criterion - edema alone diagnoses nothing, which is why an examiner will not accept it as a severe feature.
Why the distinction is urgent: severe features change management from observation to delivery planning in the next hours, not weeks. This is not chronic hypertension with superimposed proteinuria, and it is not gestational hypertension - proteinuria and the systemic findings rule both out.
One more thing I would say to the team: she is at 34 weeks 2 days, in the window where antenatal corticosteroids are still recommended when delivery is anticipated within seven days. Given an estimated fetal weight of 2,100 g and the near-certainty of a preterm birth, I would ask whether betamethasone has been ordered and involve the neonatal team now.
2. Write the magnesium sulfate and labetalol monitoring plan: what you assess, how often, what makes you stop, and why calcium gluconate is at the bedside.
Read the worked answer
Magnesium sulfate - the narrow therapeutic window Magnesium is given for seizure prophylaxis, not for blood pressure control, and it has no antidote except the one at the bedside. Monitoring is nursing-driven, which is why this is tested.
Assess hourly, with the first check 15–30 minutes into the loading dose:
- Deep tendon reflexes - they disappear at roughly 8–10 mEq/L, before respiratory depression.
- Respiratory rate and depth - respiratory depression appears around 10–12 mEq/L. I also watch oxygen saturation and talk to her: slurred speech and drowsiness are early.
- Urine output - at least 30 mL/h (0.5 mL/kg/h). Magnesium is renally excreted; oliguria means accumulation without any change in the infusion rate.
- Level as ordered, typically every 6 hours once infusing; therapeutic range 4–7 mEq/L.
- Continuous fetal monitoring - magnesium causes fetal heart rate variability to fall. A tracing that becomes flat is expected from the drug, not automatically a sign of fetal compromise, but it must be interpreted together with the magnesium level and maternal status rather than panicked over.
Stop criteria: loss of deep tendon reflexes, respiratory rate below 12/min, urine output below 30 mL/h, new confusion or somnolence, or a level above the therapeutic range. Action: stop the infusion, call the provider, apply oxygen, monitor continuously, and give calcium gluconate 1 g IV over 10 minutes as the antidote. It is at the bedside because magnesium toxicity progresses from reflex loss to respiratory arrest to cardiac arrest within minutes, and hunting for it in the medication room is not an option.
Labetalol 20 mg IV - reassess BP every 10–15 minutes after each dose and hold and call for systolic below 130–140 or diastolic below 80–90, or for maternal bradycardia, because the goal is controlled lowering, not normalization. A precipitous drop compromises uteroplacental perfusion and can produce the fetal deceleration that the magnesium was never going to cause. I would also confirm the orders include the next step-dose and a maximum, so the sequence is not improvised.
3. She asks to "wait until 37 weeks so the baby is bigger." How do you answer her, and what do you anticipate in the next 24 hours?
Read the worked answer
Answering her - honestly, without frightening her
I would not deflect this. "That is a reasonable thing to want, and it is the right instinct for a smaller baby in most pregnancies. It is not the right plan here, and I want you to understand why." Then, in plain language: the headache, the flashing lights, and the pain under her ribs are signs that the disease is affecting her brain and liver. The platelets falling to 92 tells us it is progressing. Delivery is the only treatment that stops preeclampsia; everything we are doing - the magnesium, the labetalol - buys safety on the way to delivery, it does not reverse the disease. Waiting in a patient with severe features increases the risk of seizure, placental abruption, and stroke to her, and of stillbirth to the baby. At 34 weeks with severe features, delivery is recommended, and a 2,100 g baby in a unit with neonatal support generally does well.
I would also say the quiet part: "The baby is safer out than in right now, even though that sounds backwards."
What I anticipate in the next 24 hours
- A move to delivery - likely induction with cervical ripening given 1 cm/50%/−2, or cesarean for deterioration or a non-reassuring tracing. At 1 cm and 50%, she has a long road ahead, so I would ask the team early what the plan is if her cervix does not change.
- Corticosteroids if not already given, with the recognition that severe features do not permit delaying delivery more than 24–48 hours for a full steroid course.
- A magnesium infusion continued through delivery and for 24 hours postpartum - eclampsia risk peaks after birth, so she will still be on it while she is holding her baby, which needs explaining in advance.
- Repeat labs in 6–12 hours - platelets, AST/ALT, creatinine, and a hemolysis panel; a falling platelet count accelerates everything.
- Postpartum hemorrhage prophylaxis - she is at increased risk, so I would ensure uterotonics are ordered and quantified blood loss is measured rather than estimated.
- Neonatal team at delivery for a 34-week infant, and a conversation about what to expect in the special care nursery.
Documentation: her questions, the answers given, that she verbalized understanding, and that her partner was included if she wishes.